The 13th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI) Held jointly with The German Society of Obstetrics & Gynecology
Maritim Hotel,Berlin, Germany, November 4-7, 2010
Fujirebio Diagnostics, Inc.
Company Address including:
Street: 201 Great Valley Parkway City, Zip Code: Malvern, PA 19355 Country: USA Website: www.fdi.com
Fujirebio Diagnostics, Inc. (FDI) is a premier diagnostics company and the industry leader in the development of oncology biomarkers. Fujirebio Diagnostic’s primary focus is the development, manufacture, and commercialization of in vitro diagnostic oncology products. Our core products include CA 125II a biomarker considered the gold standard for ovarian cancer. The Fujirebio Diagnostics HE4 is a new biomarker now CE-marked in Europe as an aid in estimating the risk of EOC in premenopausal or postmenopausal women presenting with pelvic mass.